Alignment Healthcare, Inc.
ALHC- Exchange
- Nasdaq
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001832466
In the last 90 days, Alignment Healthcare, Inc. insiders filed 0 open-market purchases and 9 sales; 324 institutions reported holding it in 13F filings for Q2 2026, worth $5.29B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Alignment Healthcare, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 9 filings
- 3 insiders, $23.7M in total
- Insiders trading
- 3
- Net value
- −$23.7M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Alignment Healthcare, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Konowiecki Joseph S | EVP, Corporate Affairs | 1,080,305 | Sep 18, 2026 | 10 |
| Kao John E | Chief Executive Officer | 590,766Indirect | Sep 16, 2026 | 19 |
| Maroney Dawn Christine | President | 794,606 | Sep 11, 2026 | 15 |
| Hochradel Shane J. | Chief Operations Officer | 87,719 | Jul 2, 2026 | 1 |
| Kim Hyong | Chief Medical Officer | 331,750 | Jun 15, 2026 | 6 |
| Kent Mark D. | President - MSO | 102,567 | Jun 9, 2026 | 2 |
| Head James M | Chief Financial Officer | 173,495 | Apr 8, 2026 | 2 |
| Joyce Christopher J | Chief Legal and Admin. Officer | 305,451 | Apr 1, 2026 | 6 |
| Scavo Robert L. | Chief Information Officer | 487,685 | Mar 19, 2026 | 3 |
| Burzacchi Sebastian | COO - Mgmt Services Org | 258,630 | Mar 19, 2026 | 3 |
| Wagner Andreas P. | Chief Human Resources Officer | 148,628 | Mar 19, 2026 | 4 |
| Bilney Jody L | Director | 129,267 | Mar 17, 2026 | 1 |
| Jorden Yon | Director | 105,830 | Mar 17, 2026 | 1 |
| Hodgson David C | Director | 173,408 | Mar 17, 2026 | 1 |
| Kosecoff Jacqueline B | Director | 303,963 | Mar 17, 2026 | 1 |
| McCarthy Margaret M | Director | 144,441 | Mar 17, 2026 | 1 |
| McClellan Mark B. | Director | 370,531 | Mar 17, 2026 | 1 |
| Vorhoff Nicholas Robbert | Director | 173,408 | Mar 17, 2026 | 1 |
| Mansour Adnan R. | Chief Digital Officer | 48,456 | Mar 17, 2026 | 2 |
| General Atlantic, L.P. | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| Gapco GmbH & Co KG | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| Gapco Management GmbH | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| Gap Coinvestments III, LLC | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| Gap Coinvestments IV, LLC | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| GAP Coinvestments CDA, L.P. | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| General Atlantic Genpar, L.P. | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| General Atlantic Partners 95, L.P. | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| General Atlantic (SPV) GP, LLC | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| GAP Coinvestments V, LLC | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| General Atlantic (ALN HLTH), L.P. | 10% Owner | 13,476,585Indirect | Dec 12, 2025 | 1 |
| Freeman Robert Thomas | Chief Financial Officer | 1,464,419 | Mar 28, 2025 | 0 |
| Kardes Hakan | Chief Experience Officer | 678,987 | Mar 28, 2025 | 0 |
| Margolis Jeffrey H | Director | 413,533Indirect | Aug 16, 2024 | 0 |
| Carella Thomas J. | Director | 124,478 | Mar 15, 2024 | 0 |
| Kimbro Melinda Michele | Chief People Officer | 175,439 | Jul 7, 2023 | 0 |
| Kumar Dinesh M. | Chief Med & Operating Officer | 1,088,651 | Mar 31, 2023 | 0 |
| Cross Richard A. | SVP, General Counsel | 393,460 | Mar 31, 2023 | 0 |
| Warburg Pincus & Co. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Partners GP LLC | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Partners II Holdings, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus LLC | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| WP Global LLC | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Private Equity XII, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Private Equity XII-B, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Private Equity XII-D, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Private Equity XII-E, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus XII Partners, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| WP XII Partners, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus Partners II, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
| Warburg Pincus XII, L.P. | Director, 10% Owner | 17,922,779Indirect | Sep 20, 2022 | 0 |
Showing the 50 most recent filers.
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 (view filing)11:09 AM ET | Aug 9 | 7 daysLate | Warburg Pincus & Co. and 2 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −2.12M | $16.16 | −$34.3M | −9.3%20.6M after | Duplicate filing |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Maroney Dawn ChristinePresident, Markets | SSale | −1.79K | $16.60 | −$29.7K | −0.1%1.61M after | |
| Aug 24, 2022 (view filing) | Aug 22-23 | 2 days | Maroney Dawn ChristinePresident, Markets | SSale | −30.0K | $15.91 | −$477.4K | −1.9%1.58M after | 2 lots |
| Aug 24, 2022 (view filing)5:23 PM ET | Aug 23 | 1 day | Warburg Pincus LLC and 9 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −682.0K | $15.50 | −$10.6M | −3.3%20.0M after | |
| Aug 24, 2022 (view filing)5:29 PM ET | Aug 23 | 1 day | Warburg Pincus & Co. and 2 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −682.0K | $15.50 | −$10.6M | −3.3%20.0M after | Duplicate filing |
| Aug 25, 2022 (view filing) | Aug 23 | 2 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −50.0K | $16.00 | −$800.0K | −4.7%1.01M after | |
| Sep 2, 2022 (view filing) | Sep 1 | 1 day | Freeman Robert ThomasChief Financial Officer | SSale | −24.0K | $14.56 | −$349.4K | −3.9%592.5K after | |
| Sep 2, 2022 (view filing) | Sep 1 | 1 day | Kao John EChief Executive Officer | SSale | −50.0K | $14.56 | −$728.0K | −1.8%2.80M after | |
| Sep 2, 2022 (view filing) | Sep 1 | 1 day | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −30.0K | $14.56 | −$436.8K | −3.0%976.9K after | |
| Sep 2, 2022 (view filing) | Sep 1 | 1 day | Maroney Dawn ChristinePresident, Markets | SSale | −20.0K | $14.56 | −$291.2K | −1.3%1.56M after | |
| Sep 9, 2022 (view filing) | Sep 8 | 1 day | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −50.0K | $16.05 | −$802.5K | −5.1%926.9K after | |
| Sep 9, 2022 (view filing) | Sep 9 | Same day | Maroney Dawn ChristinePresident, Markets | SSale | −10.3K | $16.60 | −$170.2K | −0.7%1.55M after | |
| Sep 20, 2022 (view filing) | Sep 20 | Same day | General Atlantic (ALN HLTH), L.P.Director, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −6.96M | $14.61 | −$101.6M | −10.2%61.0M after | |
| Sep 20, 2022 (view filing)4:50 PM ET | Sep 20 | Same day | General Atlantic, L.P. and 9 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −6.96M | $14.61 | −$101.6M | −10.2%61.0M after | Duplicate filing |
| Sep 20, 2022 (view filing)5:59 PM ET | Sep 20 | Same day | Warburg Pincus LLC and 9 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −2.04M | $14.61 | −$29.9M | −10.2%17.9M after | |
| Sep 20, 2022 (view filing)6:00 PM ET | Sep 20 | Same day | Warburg Pincus & Co. and 2 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 per share | −2.04M | $14.61 | −$29.9M | −10.2%17.9M after | Duplicate filing |
| Oct 5, 2022 (view filing) | Oct 3 | 2 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −20.0K | $12.03 | −$240.6K | −1.7%1.19M after | |
| Oct 28, 2022 (view filing) | Oct 26 | 2 days | Kao John EChief Executive Officer | SSale | −25.0K | $13.07 | −$326.8K | −0.9%2.77M after | |
| Oct 28, 2022 (view filing) | Oct 26 | 2 days | Freeman Robert ThomasChief Financial Officer | SSale | −24.0K | $13.08 | −$313.9K | −4.1%568.5K after | |
| Oct 28, 2022 (view filing) | Oct 26 | 2 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −10.0K | $13.02 | −$130.2K | −0.8%1.18M after | |
| Nov 2, 2022 (view filing) | Nov 1 | 1 day | Kao John EChief Executive Officer | SSale | −25.0K | $13.23 | −$330.8K | −0.9%2.75M after | |
| Nov 2, 2022 (view filing) | Nov 1 | 1 day | Freeman Robert ThomasChief Financial Officer | SSale | −24.0K | $13.23 | −$317.5K | −4.2%544.5K after | |
| Nov 2, 2022 (view filing) | Nov 1 | 1 day | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −30.0K | $13.39 | −$401.7K | −2.5%1.15M after | |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Kao John EChief Executive Officer | SSale | −25.0K | $13.11 | −$327.8K | −0.9%2.72M after | |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Freeman Robert ThomasChief Financial Officer | SSale | −24.0K | $13.10 | −$314.4K | −4.4%520.5K after | |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −20.0K | $13.08 | −$261.6K | −1.7%1.13M after | |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Maroney Dawn ChristinePresident, Markets | SSale | −726 | $12.02 | −$8.73K | 0.0%1.97M after | |
| Dec 22, 2022 (view filing) | Dec 21 | 1 day | Maroney Dawn ChristinePresident, Markets | SSale | −4.27K | $12.01 | −$51.3K | −0.2%1.97M after | |
| Jan 5, 2023 (view filing) | Jan 3 | 2 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −1.00K | $12.01 | −$12.0K | −0.1%1.13M after | |
| Jan 18, 2023 (view filing) | Jan 13 | 5 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −9.00K | $12.09 | −$108.8K | −0.8%1.12M after | |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Maroney Dawn ChristinePresident, Markets | SSale | −5.00K | $12.54 | −$62.7K | −0.3%1.97M after | |
| Jan 20, 2023 (view filing) | Jan 18 | 2 days | Freeman Robert ThomasChief Financial Officer | SSale | −1.10K | $13.01 | −$14.3K | −0.2%519.4K after | |
| Jan 20, 2023 (view filing) | Jan 18 | 2 days | Kao John EChief Executive Officer | SSale | −1.10K | $13.01 | −$14.3K | 0.0%2.72M after | |
| Jan 20, 2023 (view filing) | Jan 18 | 2 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −1.13K | $13.01 | −$14.6K | −0.1%1.12M after | |
| Feb 3, 2023 (view filing) | Feb 1 | 2 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −10.0K | $12.19 | −$121.9K | −0.9%1.11M after | |
| Mar 10, 2023 (view filing) | Mar 9 | 1 day | Konowiecki Joseph SChairman of the Board | PPurchase | +100.0K | $6.62 | +$662.0K | +10.9%1.02M after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Maroney Dawn ChristinePresident, Markets | SSale | −20.0K | $6.33 | −$126.6K | −1.0%1.94M after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Kao John EChief Executive Officer | SSale | −39.1K | $6.33 | −$247.5K | −1.6%2.38M after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Cross Richard A.SVP, General Counsel | SSale | −5.52K | $6.33 | −$34.9K | −1.4%395.2K after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −14.2K | $6.33 | −$89.7K | −1.3%1.09M after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Freeman Robert ThomasChief Financial Officer | SSale | −13.5K | $6.33 | −$85.3K | −1.8%718.0K after | |
| Mar 31, 2023 (view filing) | Mar 29 | 2 days | Cross Richard A.SVP, General Counsel | SSale | −1.71K | $6.11 | −$10.4K | −0.4%393.5K after | |
| Mar 31, 2023 (view filing) | Mar 29 | 2 days | Kumar Dinesh M.Chief Med & Operating Officer | SSale | −3.29K | $6.11 | −$20.1K | −0.3%1.09M after | |
| Mar 31, 2023 (view filing) | Mar 29 | 2 days | Kao John EChief Executive Officer | SSale | −34.5K | $6.11 | −$210.8K | −1.4%2.35M after | |
| Mar 31, 2023 (view filing) | Mar 29 | 2 days | Maroney Dawn ChristinePresident, Markets | SSale | −7.18K | $6.11 | −$43.9K | −0.4%1.93M after | |
| Mar 31, 2023 (view filing) | Mar 29-31 | 2 days | Freeman Robert ThomasChief Financial Officer | SSale | −8.60K | $6.17 | −$53.1K | −1.2%709.4K after | 2 lots |
| Sep 15, 2023 (view filing) | Sep 13 | 2 days | Joyce Christopher JChief Legal and Admin. Officer | SSale | −15.5K | $5.20 | −$80.5K | −5.5%267.8K after | |
| Oct 18, 2023 (view filing) | Oct 16 | 2 days | Margolis Jeffrey HDirector | SSale | −6.00K | $8.00 | −$48.0K | −1.4%419.5K after | 10b5-1 |
| Nov 15, 2023 (view filing) | Nov 10 | 5 daysLate | Konowiecki Joseph SChairman of the Board | SSale | −4.90K | $5.90 | −$28.9K | −0.4%1.19M after | |
| Dec 7, 2023 (view filing) | Dec 6 | 1 day | Margolis Jeffrey HDirector | SSale | −1.20K | $8.00 | −$9.60K | −0.3%418.3K after | 10b5-1 |